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❚ Evidence summary
No studies specifically examine the risk of
adverse outcomes for women who have
mild elevations in blood pressure as a result
of taking OCs. However, for the general
population cardiovascular risk increases
30% for each 10 mm Hg rise in systolic
pressure.1
A prospective cohort study found an
increased incidence of new hypertension
developing among women taking OCs.
The study, conducted in the US, included
68,297 female nurses aged 25 to 42 years
without a previous diagnosis of hyperten-
sion, diabetes, coronary heart disease,
stroke, or cancer, who were followed for 4
years. Women were excluded from the
study if they had not had a physical exam
in the last 2 years or were taking antihyper-
tensive medication at study inception. The
What is the risk of adverse 
outcomes in a woman who develops
mild hypertension from OCs?
Is an increase of 178 per million woman-
years of CV events clinically significant?
In clinical practice, we continually balance
the risks and benefits of any treatment. Oral
contraceptive pills are the most commonly
used reversible form of contraception in the
United States. Although this review 
documents an increased risk of reversible
new hypertension for women on OCs 
and a possibly significant increase in 
cardiovascular events, the clinical meaning
of these data is unclear. Is an increase of
178 per million woman-years of CV events 
clinically significant? It would be a shame 
to limit the availability of this effective 
contraception method to otherwise young
and healthy women because of this very
rare event.
Sarina Schrager, MD
University of Wisconsin
C L I N I C A L C O M M E N TA R Y
E V I D E N C E - B A S E D A N S W E R
Women who take oral contraceptives (OCs)
have an increased risk of developing new
hypertension, which returns to baseline
within 1 to 3 months of OC cessation
(strength of recommendation [SOR]: A,
based on cohort studies).
Among large populations of women 
with hypertension from all causes, risk of
adverse cardiovascular outcomes is
increased (SOR: B, based on Framingham
data). Women with pre-existing hyper-
tension who take OCs have an increased
risk of stroke and myocardial infarction (MI)
when compared with hypertensive women
who do not (SOR: B, based on case-control
studies).
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nurses self-reported their blood pressure
readings via questionnaire; medical
records were sampled to validate the accu-
racy of self-reports. After adjusting for risk
factors, current oral contraceptive use
increased the risk of developing hyperten-
sion (relative risk [RR]=1.8; 95% confi-
dence interval [CI], 1.5–2.3; corresponding
to 41.5 new cases of hypertension per
10,000 person-years).2
A systematic review of 8 case control
studies (with 4907 cases and 13,443 con-
trols) found an increased risk of stroke and
MI among hypertensive women taking
combined type OCs vs those not taking
OCs. Women with hypertension aged 20
to 24 years had an estimated CV event risk
of 312 per million woman-years while tak-
ing OCs vs 134 per million woman-years
not taking OCs. Among hypertensive
women aged 40 to 44 years, the estimated
risks were 1213 vs 529 per million
woman-years, respectively. Primary end-
points varied across the studies and statis-
tical significance was not given.3
Three studies showed that blood pres-
sure elevations due to taking oral contra-
ceptives returned to baseline with discon-
tinuation of the medication. A prospective
cohort study followed 13,358 women who
were neither pregnant nor postpartum
between the ages of 15 and 60. Women
who either initiated or resumed using OCs
experienced a statistically significant rise of
about 4 mm Hg in the systolic pressure
and 1 mm Hg in the diastolic pressure.
Women who stopped using OCs experi-
enced significant decreases in both systolic
and diastolic components (about 5 mm Hg
and 1.5 mm Hg, respectively).1 
Similarly, a survey study of 461
women attending family planning clinics
found that mean blood pressures were sig-
nificantly higher for those taking OCs than
for those using nonhormonal contracep-
tion. Elevated blood pressures correlated
with duration of current use of OCs but
returned to normal soon after stopping
OCs. The mean pressures of those who
had stopped OCs more than a month were
similar to those of women who had never
taken an OC and significantly lower than
those of women who were currently taking
OCs.4
Finally, a prospective study which fol-
lowed 32 women who had taken com-
bined OCs for 1 to 3 years and then
stopped found that blood pressures
returned to pretreatment levels at 3
months. Systolic pressure fell by 9.7 mm
Hg and diastolic by 2.9 mm Hg compared
with measurements made 1 month before
stopping. No cardiovascular complications
were reported among women during this
study.5
Recommendations from others
The American College of Obstetricians
and Gynecologists says that women with
well-controlled and monitored hyperten-
sion aged 35 years and younger are appro-
priate candidates for a trial of combination
OCs, provided they are otherwise healthy,
have no evidence of end-organ vascular
disease, and do not smoke cigarettes.6 If
blood pressure remains well controlled
with careful monitoring several months
after initiating OCs, use can be continued. 
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Although there is 
a risk of reversible
new hypertension
for women on OCs,
the clinical 
meaning of these
data is unclear
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